Three-cycle fentanyl patch system contributes to stable control of plasma fentanyl concentration in gynecologic cancer pain patients
Objective: Pain affects many cancer patients in advancing stages, lowering the level of their quality of life. Morphine has long been the “gold standard” for the treatment of cancer pain; however, its side effects, particularly sedation and cognitive impairment at high doses, have encouraged the use...
Main Authors: | Chiharu Kanamori, Takanobu Kanamori, Yoshiaki Tanaka, Hideharu Kanzaki |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2011-03-01
|
Series: | Taiwanese Journal of Obstetrics & Gynecology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1028455911000076 |
Similar Items
-
Transdermal fentanyl in chronic nonmalignant pain
by: Vittorio Iorno, et al.
Published: (2006-09-01) -
Transdermal buprenorphine and fentanyl patches in cancer pain: a network systematic review
by: Ahn JS, et al.
Published: (2017-08-01) -
Fentanyl transdermal patch: The silent new killer?
by: Martina Zanon, et al.
Published: (2020-12-01) -
The use of transdermal fentanyl in the treatment of cancer pain
by: Radovanović Dragana, et al.
Published: (2002-01-01) -
Treatment of Severe Cancer Pain by Transdermal Fentanyl
by: Dženita Ljuca, et al.
Published: (2010-05-01)